1Wai PY, Kuo PC. The role of Osteopontin in tumor metastasis. J Surg Res, 2004, 121(2):228-241.
2Yeatman TJ, Chambers AF. Osteopontin and colon cancer progression. Clin Exp Metastasis, 2003, 20(1): 85-90.
3Hirama M, Takahashi F. Takahashi K, et al. Osteopontin overproduced by tumor cells acts as a potenl angiogenic factor contributing to tumor growth, Cancer Lett, 2003, 198(1): 107-117.
4Geissinger E, Weisser C, Fischer P, et al. Autocrine stimulation by osteoponlin contributes to antiapoptotic signalling of melanocytes in dermal collagen. Cancer Res, 2002, 62(16):4820-4828.
5Coppola D, Szabo M, Boulware D, et al. Correlation of osteolpontin protein expression and pathological stage across a wide variety of tumor histologies. Clin Cancer Res,2004, 10(1 Pt 1):184-190.
6Tuck AB, Hota C, Chambers AF. Osteopontin(OPN)-induced increase in human mammary epilhelial cell invasiveness is urokinase(uPA)-dependent. Breast Cancer Res Treat, 2001, 70 ( 3 ) : 197-204.
7Takano S, Tsuboi K, Tomono Y, et al, Tissue factor, osteopon-tin, alphavbeta3 integrin expression in microvasculature of gliomas associated with vascular endothelial growth factor expression. Br J Cancer, 2000, 82(12): 1967-1973.
8Schorge JO, Drake RD, Lee H, et al, Osteopontin as an adjunct to CA125 in detecting recurrent ovarian cancer. Clin Cancer Res,2004, 10(10): 3474-3478.
9Wong TS, Kwong DL, Sham J, et al. Elevation of plasma osteopontin level in patients with undifferentiated nasopharyngeal carcinoma, EurJ Surg Oncol, 2005, 31(5): 555-558.
10Rudland PS, Platt-Higgins A, EI-Tanani M, et al. Prognostic significance of the metastasis-associaled protein osleopontin in human breast cancer. Cancer Res, 2002, 62(12):3417-3427.
